Surface Oncology, Inc.
SURFDelisted Sep 8, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001718108
Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Surface Oncology, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- +7 vs. Q1 2021
- Shares held
- 22.6M
- +3.74M (+19.8%) vs. Q1 2021
- Total value
- $168.5M
- +$21.5M (+14.6%) vs. Q1 2021
- New holders
- 33
- 29 more added
- Sold out
- 26
- 16 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SURF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $21.0K |
| Q3 2025 | 1 | $21.0K |
| Q2 2025 | 1 | $21.0K |
| Q1 2025 | 1 | $21.0K |
| Q4 2024 | 1 | $21.0K |
| Q3 2024 | 1 | $21.0K |
| Q2 2024 | 1 | $21.0K |
| Q1 2024 | 1 | $21.0K |
| Q4 2023 | 1 | $21.0K |
| Q3 2023 | 2 | $21.3K |
| Q2 2023 | 62 | $16.9M |
| Q1 2023 | 72 | $18.8M |
| Q4 2022 | 80 | $23.4M |
| Q3 2022 | 80 | $32.8M |
| Q2 2022 | 85 | $48.6M |
| Q1 2022 | 104 | $93.8M |
| Q4 2021 | 107 | $118.0M |
| Q3 2021 | 92 | $182.2M |
| Q2 2021 | 97 | $168.5M |
| Q1 2021 | 91 | $147.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Surface Oncology, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Davide Leone & Partners Investment Co Ltd. | 0 | $0 | 0.00% | −268,960−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −163,968−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −143,800−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −137,047−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −121,250−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −79,588−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −76,411−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −48,522−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −48,200−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −27,900−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −27,222−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −25,371−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −22,605−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −15,766−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −15,100−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −12,984−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Kestra Private Wealth Services, LLC | 0 | $0 | 0.00% | −10,200−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,088−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −530−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Money Concepts Capital Corp | – | – | – | – | Not filed |